Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C

Journal of Immunoassay and Immunochemistry

Volumn 28, Issue 3, 2007, Pages 199-211

  Attallah, A M ^a   Toson, E A ^b   Shiha, G E ^c   Omran, M M ^a   Abdel Aziz, M M ^c   El Dosoky, I ^c  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

Biomarkers; Fibrosis; HCV; Liver; Procollagen III aminoterminal propeptide; Score

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOCHEMICAL MARKER; GLYCINE; HYDROXYPROLINE; LAMININ; PROCOLLAGEN III AMINOTERMINAL PROPEPTIDE; PROLINE; PROTEIN; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTHROMBIN TIME; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION PROCESS;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN TYPE III; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; HYDROXYPROLINE; LAMININ; MALE; MIDDLE AGED; PEPTIDES; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34347376488     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701454649     Document Type: Article

References (37)

1. Brenner, D.A.; Waterboer, T.; Choi, S.K.; Lindquist, J.N.; Stefanovic, B.; Burchardt, E.; Yamauchi, M.; Gillan, A.; Rippe, R.A. New aspects of hepatic fibrosis. J. Hepatol. 2000, 32 (1), 32-38.
2. 'Cadranel, J.F. Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol. Clin. Biol. 2002, 26 (10), 823-824.
3. Halfon, P.; Bourliere, M.; Penaranda, G.; Deydier, R.; Renou, C.; Botta-Fridlund, D.; Tran, A.; Portal, I.; Allemand, I.; Rosenthal-Allieri, A.; Ouzan, D. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp. Hepatol. 2005, 4, 6.
4. Attallah, A.M.; Shiha, G.E.; Omran, M.M.; Zalata, K.R. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol. Res. 2006, 34 (3), 163-169.
5. Pohl, A.; Behling, C.; Oliver, D.; Kilani, M.; Monson, P.; Hassanein, T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am. J. Gastroenterol. 2001, 96 (11), 3142-3146.
6. Guechot, J.; Poupon, R.E.; Giral, P.; Balkau, B.; Giboudeau, J.; Poupon, R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J. Hepatol. 1994, 20 (3), 388-393.
7. Santos, V.N.; Leite-Mor, M.M.; Kondo, M.; Martins, J.R.; Nader, H.; Lanzoni, V.P. Parise, E.R. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz. J. Med. Biol. Res. 2005, 38 (5), 747-753.
8. Guechot, J.; Laudat, A.; Loria, A.; Serfaty, L.; Poupon, R.; Giboudeau, J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin. Chem. 1996, 42 (4), 558-563.
9. Babbs, C.; Smith, A.; Hunt, L.P.; Rowan, B.P.; Haboubi, N.Y.; Warnes, T.W. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet 1988, I (8593), 1021-1024.
10. Lee, H.S.; Shun, C.T.; Chiou, L.L.; Chen, C.H.; Huang, G.T.; Sheu, J.C. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J. Gastroenterol. Hepatol. 2005, 20 (7), 1109-1114.
11. Ponomarenko, Y.; Leo, M.A.; Kroll, W.; Lieber, C.S. Effects of alcohol consumption on eight circulating markers of liver fibrosis. Alcohol Alcohol 2002, 37 (3), 252-255.
12. Ishak, K.; Baptista, A.; Bianchi, L.; Callea, F.; De Groote, J.; Gudat, F.; Denk, H.; Desmet, V.; Korb, G.; MacSween, R.N. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995, 22 (6), 696-699.
13. Stone, K.L.; Williams, K.R. High-performance liquid chromatographic peptide mapping and amino acid analysis in the sub-nanomole range. J. Chromatogr. 1986, 30, 203-212.
14. Zweig, M.H.; Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39 (4), 561-577.
15. Huguet, J.; Castineiras, M.J.; Fuentes-Arderiu, X. Diagnostic accuracy evaluation using ROC curve analysis. Scand. J. Clin. Lab. Invest. 1993, 53 (7), 693-699.
16. Attallah, A.M. Abdel Malak, C.A.; Elghawalby, N.A.; Shehatta, A.S.; Abdel-Raouf, M.; Shiha, G.E. Identification of a specific marker for hepatitis C virus infection using capillary zone electrophoresis. Clin. Chim. Acta. 2004, 346 (2), 171-179.
17. Attallah, A.M.; Ismail, H.; Tabll, A.A.; Shiha, G.E.; El-Dosoky, I. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection. J. Immunoassay Immunochem. 2003, 24 (4), 395-407.
18. Attallah, A.M.; Shiha, G.E.; AbdelMalak, C.A.; Hagras, H.E.; Abdel-Razik, W.S.; Ismail, H. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV-infected individuals with pegylated interferon α-2a. Hepatol. Res. 2004, 28 (2), 68-72.
19. Oh, S.; Afdhal, N.H. Hepatic fibrosis: are any of the serum markers useful? Curr. Gastroenterol. Rept. 2001, 3 (1), 12-18.
20. Stone, P.J. Potential use of collagen and elastin degradation markers for monitoring liver fibrosis in schistosomiasis. Acta. Trop. 2000, 77 (1), 97-99.
21. Zheng, M.; Cai, W.M.; Weng, H.L.; Liu, R.H. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J. Gastroenterol. 2002, 8 (6), 1073-1076.
22. Risteli, J.; Sogaard, H.; Oikarinen, A.; Risteli, L.; Karvonen, J.; Zachariae, H. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis. Brit. J. Dermatol. 1988, 119 (3), 321-325.
23. Gabrielli, G.B.; Capra, F.; Casaril, M.; Corrocher, R.; Colombari, R.; De Sandre, G. Serum laminin P1 in chronic viral hepatitis: correlations with liver histological activity and diagnostic value. Clin. Chim. Acta 1996, 252 (2), 171-180.
24. Inoue, H.; Date, Y.; Kohashi, K.; Yoshitomi, H.; Tsuruta, Y. Determination of total hydroxyproline and proline in human serum and urine by HPLC with fluorescence detection. Biol. Pharm. Bull. 1996, 19 (2), 163-166.
25. Schulze-Krebs, A.; Preimel, D.; Popov, Y.; Bartenschlager, R.; Lohmann, V.; Pinzani, M.; Schuppan, D. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterol. 2005, 129 (1), 246-258.
26. Schneider, M.; Voss, B.; Hogemann, B.; Eberhardt, G.; Gerlach, U. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Hepatogastroenterology 1989, 36 (6), 506-510.
27. Castera, L.; Hartmann, D.J.; Chapel, F.; Guettier, C.; Mall, F.; Lons, T.; Richardet, J.P.; Grimbert, S.; Morassi, O.; Beaugrand, M.; Trinchet, J.C. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J. Hepatol. 2000, 32 (3), 412-418.
28. Lu, L.G.; Zeng, M.D.; Mao, Y.M.; Li, J.Q.; Qiu, D.K.; Fang, J.Y.; Cao, A.P.; Wan, M.B.; Li, C.Z.; Ye, J.; Cai, X.; Chen, C.W.; Wang, J.Y.; Wu, S.M.; Zhu, J.S.; Zhou, X.Q. Relationship between clinical and pathologic findings in patients with chronic liver diseases. World J. Gastroenterol. 2003, 9 (12), 2796-2800.
29. Walsh, K.M.; Fletcher, A.; Mac Sween, R.N.; Morris, A.J. Basement membrane peptides as markers of liver disease in chronic hepatitis C. J. Hepatol. 2000, 32 (2), 325-330.
30. Guechot, J.; Laudat, A.; Loria, A.; Serfaty, L.; Poupon, R.; Giboudeau, J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin. Chem. 1996, 42 (4), 558-563.
31. Myers, R.P.; De Torres, M.; Imbert-Bismut, F.; Ratziu, V.; Charlotte, F.; Poynard, T. Multivirc Group. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig. Dis. Sci. 2003, 48 (1), 146-153.
32. Shimada, M.; Matsumata, T.; Adachi, E.; Itasaka, H.; Watiyama, S.; Sugimachi, K. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens. Hepatogastroenterology 1994, 41 (2), 177-180.
33. Benlloch, S.; Berenguer, M.; Prieto, M.; Rayon, J.M.; Aguilera, V.; Berenguer, J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl. 2005, 11 (4), 456-462.
34. Forns, X.; Ampurdanes, S.; Llovet, J.M.; Aponte, J.; Quinto, L.; Martinez-Bauer, E.; Bruguera, M.; Sanchez-Tapias, J.M.; Rodes, J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatol. 2002, 36 (4), 986-992.
35. Attallah, A.M.; Toson, el-S.A.; El-Waseef, A.M.; Abo-Seif, M.A.; Omran, M.M.; Shiha, G.E. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clin. Chim. Acta. 2006, 15, 369 (1), 66-72.
36. Rossi, E.; Adams, L.; Prins, A.; Bulsara, M.; de Boer, B.; Garas, G.; MacQuillan, G.; Speers, D.; Jeffrey, G. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin. Chem. 2003, 49 (3), 450-454.
37. Pagliaro, L.; Rinaldi, F.; Craxi, A.; Di Piazza, S.; Filippazzo, G.; Gatto, G.; Genova, G.; Magrin, S.; Maringhini, A.; Orsini, S.; Palazzo, U.; Spinello, M.; Vinci, M. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig. Dis. Sci. 1983, 28 (1), 39-43.